Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vinyl Ether SCHEMBL3312929 | 0.87 | — | — | |
| Acrylamide SCHEMBL3682251 | 0.86 | ALDH1A1 (0.58) | ALDH1A1TSHRFGFR4LMNA | |
| Vinyl Ether SCHEMBL9622539 | 0.84 | — | — | |
| Acrylamide SCHEMBL1332254 | 0.83 | — | — | |
| Acrylamide SCHEMBL1332245 | 0.83 | — | — | |
| Acrylamide SCHEMBL183292 | 0.83 | TSHR (1.00) | ALDH1A1TSHRFGFR4LMNA | |
| Acrylamide SCHEMBL170034 | 0.83 | TSHR (1.00) | ALDH1A1TSHRFGFR4LMNA | |
| Acrylamide SCHEMBL3051 | 0.83 | — | — | |
| Acrylamide SCHEMBL5139618 | 0.80 | — | — | |
| Acrylamide SCHEMBL9578583 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114773523-A | Water-based fluorine-containing waterproof and oil-proof agent for paper and preparation and application thereof | 浙江大学衢州研究院 | 2022-07-22 | — | — | CN | claimed |
| JP-2077403-A | — | — | None | — | — | JP | disclosed |
| CN-111615405-B | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | 国家科学研究中心 | 2023-11-28 | — | — | CN | disclosed |
| US-20200353090-A1 | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | Universite Paris-Saclay (FR) | 2020-11-12 | — | — | US | disclosed |
| EP-3710061-A1 | POLYMER PRODRUGS AND SUBCUTANEOUS AND/OR INTRAMUSCULAR ADMINISTRATION THEREOF | Centre National de la Recherche Scientifique (FR) | 2020-09-23 | — | — | EP | disclosed |
| CN-111615405-A | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | 国家科学研究中心 | 2020-09-01 | — | — | CN | disclosed |
| US-8734533-B2 | Composition for application to a surface | S.C. JOHNSON & SON, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| US-20100256263-A1 | COMPOSITION FOR APPLICATION TO A SURFACE | S.C. JOHNSON & SON, INC. (US) | 2010-10-07 | — | — | US | disclosed |
| US-7776108-B2 | Composition for application to a surface | S.C. JOHNSON & SON, INC. (US) | 2010-08-17 | — | — | US | disclosed |
| US-20090271933-A1 | Composition For Application To A Surface | S.C. JOHNSON & SON, INC. (US) | 2009-11-05 | — | — | US | disclosed |
| US-5432033-A | Toner, developer, high density, resolution | HITACHI METALS, LTD. (JP) | 1995-07-11 | — | — | US | disclosed |
| JP-H0277403-A | PHOTOCURABLE AND THERMOSETTING POLYVINYL BUTYRAL DERIVATIVE | SHIN ETSU CHEM CO LTD | 1990-03-16 | — | — | JP | disclosed |
| EP-0164257-A2 | Toner for developing electrostatic latent image | KONICA CORPORATION (JP) | 1985-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200353090-A1 | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | IDE, SI, PYGM | ALDH1A1 385/4885TSHR 3972/4885FGFR4 3673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.